Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Oral Oncol. 2023 Mar 15;139:106362. doi: 10.1016/j.oraloncology.2023.106362

Table 4.

Univariate Analysis of Factors on Overall Survival and Recurrence, N2b patients.

Recurrence-free Survival Overall Survival
HR (95 % CI) (n = 71, 5 events) HR (95 % CI) (n = 71, 8 events)

Age 1.01 (0.91, 1.11) 0.99 (0.91, 1.08)
Smoking Packs/Year
 0 ref ref
 1–10 2.70 (0.17, 43.27) 5.05 (0.45, 55.72)
 >10 2.89 (0.30, 27.78) 3.96 (0.44, 35.47)
Clinical Tumor (T) 7th Stage
 1 ref
 2 3.08 (0.37–25.67)
Tumor Size (cm) 0.88 (0.23, 3.29) 1.00 (0.37, 2.75)
Soft Palate/Base of Tongue
 Extension
 Yes ref ref
 No 0.54 (0.09, 3.22) 0.81 (0.16, 4.22)
Nodal Size (cm) 0.98 (0.42, 2.25) 1.01 (0.49, 2.05)
Side(s) of Neck Irradiated
 Bilateral ref ref
 Ipsilateral 0.50 (0.84–3.01) 1.22 (0.27, 5.48)
Adjuvant Neck Dissection
 No ref ref
 Yes 0.57 (0.06, 5.15) 0.70 (0.13, 3.68)